Charities blast epilepsy medication braille error

Image shows generic medication with braille labelling 

Sight Scotland, Sight Scotland Veterans and Epilepsy Scotland have criticised the Medicines and Healthcare products Regulatory Agency (MHRA) for failing to recall epilepsy medication containing a braille error on the packaging.

The MHRA decided not to recall 70% of affected batches of 500mg film-coated Keppra tablets repackaged with braille indicating the strength to be 1,000mg, as it said the quality was not compromised.

Craig Spalding, chief executive of Sight Scotland and Sight Scotland Veterans, said: ‘We are deeply concerned and shocked by this decision and firmly believe that the medication should be recalled. Accurate dosage is crucial, particularly with Keppra, one of the most prescribed anti-seizure medications.

Register now to continue reading

Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.


Already have an account? Sign in here